Knogletæthedsmåling og biomarkører til monitorering af osteoporosebehandling

TY - JOUR

T1 - Knogletæthedsmåling og biomarkører til monitorering af osteoporosebehandling

AU - Pedersen, Søren Bønløkke

AU - Rand, Michael Schønemann

AU - Eiken, Pia A

AU - Jørgensen, Niklas Rye

PY - 2018

Y1 - 2018

N2 - This review discusses two methods of monitoring the effect of anti-osteoporotic treatment: bone mineral density (BMD) and bone turnover markers (BTMs). Both monitoring strategies are to some extent able to predict the treatment-induced change in risk of fracture. The use of BMD is commonplace, and clinicians are experienced in the interpretation of data. The use and knowledge of BTMs among clinicians is limited, but it allows for early testing while being practical and cheap. Further knowledge and implementation of BTMs in the clinical practice may improve the monitoring capabilities.

AB - This review discusses two methods of monitoring the effect of anti-osteoporotic treatment: bone mineral density (BMD) and bone turnover markers (BTMs). Both monitoring strategies are to some extent able to predict the treatment-induced change in risk of fracture. The use of BMD is commonplace, and clinicians are experienced in the interpretation of data. The use and knowledge of BTMs among clinicians is limited, but it allows for early testing while being practical and cheap. Further knowledge and implementation of BTMs in the clinical practice may improve the monitoring capabilities.

M3 - Tidsskriftartikel

C2 - 30070630

SN - 0041-5782

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 32

M1 - V12170926

ER -